PE20120420A1 - 5-(2-{[6-(2,2-difluoro-2-feniletoxihexil] amino}-1-hidroxietil)-8-hidroxiquinolin-2(ih)-ona como agonista de los receptores beta2 adrenergicos - Google Patents
5-(2-{[6-(2,2-difluoro-2-feniletoxihexil] amino}-1-hidroxietil)-8-hidroxiquinolin-2(ih)-ona como agonista de los receptores beta2 adrenergicosInfo
- Publication number
- PE20120420A1 PE20120420A1 PE2011001310A PE2011001310A PE20120420A1 PE 20120420 A1 PE20120420 A1 PE 20120420A1 PE 2011001310 A PE2011001310 A PE 2011001310A PE 2011001310 A PE2011001310 A PE 2011001310A PE 20120420 A1 PE20120420 A1 PE 20120420A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyletoxyhexyl
- hydroxyquinolin
- difluoro
- agonist
- hydroxyethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09382021A EP2221297A1 (de) | 2009-02-18 | 2009-02-18 | 5-(2-{[6-(2,2-Difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on und seine Verwendung bei der Behandlung von Atemwegserkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20120420A1 true PE20120420A1 (es) | 2012-05-09 |
Family
ID=40848429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011001310A PE20120420A1 (es) | 2009-02-18 | 2010-02-18 | 5-(2-{[6-(2,2-difluoro-2-feniletoxihexil] amino}-1-hidroxietil)-8-hidroxiquinolin-2(ih)-ona como agonista de los receptores beta2 adrenergicos |
Country Status (22)
Country | Link |
---|---|
US (2) | US20120040941A1 (de) |
EP (2) | EP2221297A1 (de) |
JP (2) | JP2012518020A (de) |
KR (1) | KR20110123740A (de) |
CN (2) | CN103288729A (de) |
AR (1) | AR075769A1 (de) |
AU (1) | AU2010214855A1 (de) |
BR (1) | BRPI1005932A2 (de) |
CA (1) | CA2749045A1 (de) |
CL (2) | CL2011002002A1 (de) |
CO (1) | CO6361996A2 (de) |
EA (1) | EA201101211A1 (de) |
EC (1) | ECSP11011337A (de) |
IL (1) | IL213980A0 (de) |
MX (1) | MX2011008573A (de) |
PE (1) | PE20120420A1 (de) |
PH (1) | PH12014500417A1 (de) |
SG (2) | SG173092A1 (de) |
TW (1) | TW201031409A (de) |
UY (1) | UY32435A (de) |
WO (1) | WO2010094484A1 (de) |
ZA (1) | ZA201104655B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2265276B1 (es) | 2005-05-20 | 2008-02-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
ES2302447B1 (es) * | 2006-10-20 | 2009-06-12 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
ES2306595B1 (es) * | 2007-02-09 | 2009-09-11 | Laboratorios Almirall S.A. | Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2. |
UY32297A (es) | 2008-12-22 | 2010-05-31 | Almirall Sa | Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico |
EP2228368A1 (de) | 2009-03-12 | 2010-09-15 | Almirall, S.A. | Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on |
EP2578570A1 (de) | 2011-10-07 | 2013-04-10 | Almirall, S.A. | Neues Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxychinolin-2(1H)-on mittels neuen Synthesezwischenstoffen |
EP2641900A1 (de) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Neuartige polymorphe Kristallformen von 5-(2-{[6-(2,2-difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on, Heminapadisylat als Agonist des beta2-adrenergen Rezeptors |
EP2668941A1 (de) * | 2012-05-31 | 2013-12-04 | Almirall, S.A. | Neue Darreichungsform und Formulierung von Abediterol |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT7920688V0 (it) | 1979-02-05 | 1979-02-05 | Chiesi Paolo Parma | Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore. |
DE3274065D1 (de) | 1981-07-08 | 1986-12-11 | Draco Ab | Powder inhalator |
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FI69963C (fi) | 1984-10-04 | 1986-09-12 | Orion Yhtymae Oy | Doseringsanordning |
DE3927170A1 (de) | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
IT1237118B (it) | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
DE4027391A1 (de) | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgeraet |
EP0640354B1 (de) | 1990-09-26 | 2001-12-05 | Pharmachemie B.V. | Wirbelkammer-Pulverinhalator |
GB9026025D0 (en) | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
DE4239402A1 (de) | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
MY115140A (en) | 1992-12-18 | 2003-04-30 | Schering Corp | Inhaler for powdered medications |
BR9604977A (pt) | 1995-04-14 | 1998-06-09 | Glaxo Wellcome Inc | Inalador de dose medida sistema inalador de dose medida e uso do mesmo |
HU220227B (hu) | 1995-06-21 | 2001-11-28 | Asta Medica A.G. | Gyógyszerporos patron integrált adagolószerkezettel és inhalálókészülék poralakú gyógyszerekhez |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
ES2195785B1 (es) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2211344B1 (es) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2232306B1 (es) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2251867B1 (es) | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2265276B1 (es) | 2005-05-20 | 2008-02-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
ES2306595B1 (es) | 2007-02-09 | 2009-09-11 | Laboratorios Almirall S.A. | Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2. |
-
2009
- 2009-02-18 EP EP09382021A patent/EP2221297A1/de not_active Withdrawn
-
2010
- 2010-02-10 UY UY0001032435A patent/UY32435A/es unknown
- 2010-02-12 TW TW099104707A patent/TW201031409A/zh unknown
- 2010-02-17 AR ARP100100454A patent/AR075769A1/es unknown
- 2010-02-18 US US13/202,020 patent/US20120040941A1/en not_active Abandoned
- 2010-02-18 EP EP10709683A patent/EP2398772A1/de not_active Withdrawn
- 2010-02-18 WO PCT/EP2010/001027 patent/WO2010094484A1/en active Application Filing
- 2010-02-18 CN CN2013102471118A patent/CN103288729A/zh active Pending
- 2010-02-18 SG SG2011052826A patent/SG173092A1/en unknown
- 2010-02-18 SG SG2014009872A patent/SG2014009872A/en unknown
- 2010-02-18 BR BRPI1005932A patent/BRPI1005932A2/pt not_active IP Right Cessation
- 2010-02-18 PE PE2011001310A patent/PE20120420A1/es not_active Application Discontinuation
- 2010-02-18 MX MX2011008573A patent/MX2011008573A/es not_active Application Discontinuation
- 2010-02-18 JP JP2011550475A patent/JP2012518020A/ja active Pending
- 2010-02-18 AU AU2010214855A patent/AU2010214855A1/en not_active Abandoned
- 2010-02-18 EA EA201101211A patent/EA201101211A1/ru unknown
- 2010-02-18 CA CA2749045A patent/CA2749045A1/en not_active Abandoned
- 2010-02-18 CN CN2010800082336A patent/CN102317264A/zh active Pending
- 2010-02-18 KR KR1020117018646A patent/KR20110123740A/ko not_active Application Discontinuation
-
2011
- 2011-06-23 ZA ZA2011/04655A patent/ZA201104655B/en unknown
- 2011-07-07 IL IL213980A patent/IL213980A0/en unknown
- 2011-08-12 CO CO11102789A patent/CO6361996A2/es not_active Application Discontinuation
- 2011-08-17 CL CL2011002002A patent/CL2011002002A1/es unknown
- 2011-09-16 EC EC2011011337A patent/ECSP11011337A/es unknown
-
2013
- 2013-10-08 US US14/048,344 patent/US20140038928A1/en not_active Abandoned
-
2014
- 2014-02-21 PH PH12014500417A patent/PH12014500417A1/en unknown
- 2014-03-04 CL CL2014000531A patent/CL2014000531A1/es unknown
- 2014-08-15 JP JP2014165548A patent/JP2015028029A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2010094484A1 (en) | 2010-08-26 |
AU2010214855A1 (en) | 2011-07-21 |
SG2014009872A (en) | 2014-04-28 |
MX2011008573A (es) | 2011-09-06 |
CL2014000531A1 (es) | 2014-09-05 |
CN103288729A (zh) | 2013-09-11 |
IL213980A0 (en) | 2011-08-31 |
BRPI1005932A2 (pt) | 2017-05-02 |
CL2011002002A1 (es) | 2011-11-11 |
CO6361996A2 (es) | 2012-01-20 |
SG173092A1 (en) | 2011-08-29 |
PH12014500417A1 (en) | 2015-10-19 |
ZA201104655B (en) | 2012-02-29 |
AR075769A1 (es) | 2011-04-27 |
JP2012518020A (ja) | 2012-08-09 |
TW201031409A (en) | 2010-09-01 |
EA201101211A1 (ru) | 2012-03-30 |
US20120040941A1 (en) | 2012-02-16 |
JP2015028029A (ja) | 2015-02-12 |
KR20110123740A (ko) | 2011-11-15 |
ECSP11011337A (es) | 2011-10-31 |
EP2398772A1 (de) | 2011-12-28 |
CA2749045A1 (en) | 2010-08-26 |
CN102317264A (zh) | 2012-01-11 |
EP2221297A1 (de) | 2010-08-25 |
UY32435A (es) | 2010-05-31 |
US20140038928A1 (en) | 2014-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20120420A1 (es) | 5-(2-{[6-(2,2-difluoro-2-feniletoxihexil] amino}-1-hidroxietil)-8-hidroxiquinolin-2(ih)-ona como agonista de los receptores beta2 adrenergicos | |
PE20081752A1 (es) | Sal de napadisilato de 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2-(1h)-ona como agonista del receptor adrenergico b2 | |
PE20160173A1 (es) | SALES DE DERIVADOS DE 2-AMINO-1-HIDROXIETIL-8-HIDROXIQUINOLIN-2(1H)-ONA QUE TIENEN ACTIVIDAD ANTAGONISTA DE RECEPTORES MUSCARINICOS ASI COMO ACTIVIDAD AGONISTA DEL RECEPTOR ß2 ADRENERGICO | |
CL2011001544A1 (es) | Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1-(r)-hidroxietil}-8-hidroxiquinolin-2(1h)-ona; agonista de los receptores beta 2 adrenergico; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de asma o enfermedad pulmonar obstructiva cronica. | |
PE20141205A1 (es) | Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores de bace1 y/o bace2 | |
JO3421B1 (ar) | طريقة لإعطاء 1-((1ار.3س)-6-كلورو-3-فينيل-اندان-1-ايل)-1.2.2-ترايميثيل- بيبيرازين واملاجها لمعالجة انفصام الشخصية | |
SV2010003642A (es) | Compuestos | |
EA201592082A1 (ru) | 3,4-дигидроизохинолин-2(1h)-ильные соединения | |
UY32296A (es) | Nuevos compuestos | |
PE20140831A1 (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinolina util para el tratamiento de diabetes | |
PE20140934A1 (es) | Derivados de pirazol | |
EA201100612A1 (ru) | Новые производные 2-амидотиадиазола | |
ECSP11011336A (es) | 5- (2-{ [6- (2, 2-difluoro-2-feniletoxi) hexil] amino} -1-hidroxietil) -8-hidroxiquinolin-2 (ih)-ona para el tratamiento pulmonar. | |
EA201000316A1 (ru) | Производные изохинолинила и изоиндолинила в качестве антагонистов гистаминовых рецепторов 3 подтипа | |
PE20141169A1 (es) | Derivados de etinilo | |
PH12016500989B1 (en) | Crystalline salt of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonists | |
MX2015013328A (es) | Uso de antagonistas del receptor de ep4 en el tratamiento de enfermedad de cartilago. | |
CL2011002212A1 (es) | Procedimiento para la preparacion de 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona utilizando xileno como solvente. | |
CR20140433A (es) | Nuevas formas cristalinas polimorficas de 5-(2-{[6-(2,2-difluoro -2-feniletoxi) hexil] amino}-1-(r)-hidroxietil)-8-hidroxiquinolin-2 (1h)-ona, heminapadisilato como agonista del receptor adrenergico b2 | |
BR112014007891A2 (pt) | processo para preparar 5-(2-{[6-(2,2-difluoro-2-feniletóxi)hexil]amino}-1(r)-hidroxietil)-8-hidroxiquinolin-2(1h)-ona através de um intermediário | |
EA201391348A1 (ru) | КОМБИНАЦИИ АКТИВАТОРОВ АЛЬФА-7 НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА И АНТАГОНИСТОВ mGluR5, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ПРИМЕНЕНИЯ ПРИ ВЫЗВАННОЙ ДОПАМИНОМ ДИСКИНЕЗИИ, СВЯЗАННОЙ С БОЛЕЗНЬЮ ПАРКИНСОНА | |
UY33283A (es) | Derivados de 2,3-dihidro-1h-inden-1-il-2,7-diazaspiro[3.5]nonano |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |